27467251|t|An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps
27467251|a|Previous studies have demonstrated that microRNA-132 plays a vital part in and is actively associated with several cancers, with its tumor-suppressive role in hepatocellular carcinoma confirmed. The current study employed multiple bioinformatics techniques to establish gene signatures for hepatocellular carcinoma, microRNA-132 predicted target genes and the corresponding overlaps. Various assays were performed to explore the role and cellular functions of miR-132 in HCC and a successive panel of tasks was completed, including NLP analysis, miR-132 target genes prediction, comprehensive analyses (gene ontology analysis, pathway analysis, network analysis and connectivity analysis), and analytical integration. Later, HCC - related and miR-132 - related potential targets, pathways, networks and highlighted hub genes were revealed as well as those of the overlapped section. MiR-132 was effective in both impeding cell growth and boosting apoptosis in HCC cell lines. A total of fifty-nine genes were obtained from the analytical integration, which were considered to be both HCC - and miR-132 - related. Moreover, four specific pathways were unveiled in the network analysis of the overlaps, i.e. adherens junction, VEGF signaling pathway, neurotrophin signaling pathway, and MAPK signaling pathway. The tumor-suppressive role of miR-132 in HCC has been further confirmed by in vitro experiments. Gene signatures in the study identified the potential molecular mechanisms of HCC, miR-132 and their established associations, which might be effective for diagnosis, individualized treatments and prognosis of HCC patients. However, combined detections of miR-132 with other bio-indicators in clinical practice and further in vitro experiments are needed.
27467251	3	16	Encapsulation	T067	C2348438
27467251	20	35	Gene Signatures	T169	C1708225
27467251	40	64	Hepatocellular Carcinoma	T191	C2239176
27467251	66	78	MicroRNA-132	T114,T123	C2745279
27467251	79	88	Predicted	T078	C0681842
27467251	89	101	Target Genes	T028	C1332838
27467251	110	132	Corresponding Overlaps	T086	C0314659
27467251	142	149	studies	T062	C2603343
27467251	173	185	microRNA-132	T114,T123	C2745279
27467251	224	239	associated with	T080	C0332281
27467251	248	255	cancers	T191	C0006826
27467251	266	288	tumor-suppressive role	T043	C1325410
27467251	292	316	hepatocellular carcinoma	T191	C2239176
27467251	317	326	confirmed	T080	C0521093
27467251	340	345	study	T062	C2603343
27467251	355	363	multiple	T081	C0439064
27467251	364	389	bioinformatics techniques	T169	C0449851
27467251	403	418	gene signatures	T169	C1708225
27467251	423	447	hepatocellular carcinoma	T191	C2239176
27467251	449	461	microRNA-132	T114,T123	C2745279
27467251	462	471	predicted	T078	C0681842
27467251	472	484	target genes	T028	C1332838
27467251	493	515	corresponding overlaps	T086	C0314659
27467251	525	531	assays	T059	C1510438
27467251	537	546	performed	T169	C0884358
27467251	562	566	role	T080	C0205556
27467251	571	589	cellular functions	T043	C0007613
27467251	593	600	miR-132	T114,T123	C2745279
27467251	604	607	HCC	T191	C2239176
27467251	614	630	successive panel	T062	C0681848
27467251	644	653	completed	T080	C0205197
27467251	665	668	NLP	T066	C0027489
27467251	669	677	analysis	T062	C0936012
27467251	679	686	miR-132	T114,T123	C2745279
27467251	687	699	target genes	T028	C1332838
27467251	700	710	prediction	T078	C0681842
27467251	712	725	comprehensive	T080	C1880156
27467251	726	734	analyses	T062	C0936012
27467251	736	758	gene ontology analysis	T170	C1138831
27467251	760	776	pathway analysis	T170	C0868995
27467251	778	794	network analysis	T170	C0868995
27467251	799	811	connectivity	T169	C1707489
27467251	812	820	analysis	T062	C0936012
27467251	827	849	analytical integration	T169	C0205245
27467251	858	861	HCC	T191	C2239176
27467251	864	871	related	T080	C0439849
27467251	876	883	miR-132	T114,T123	C2745279
27467251	886	893	related	T080	C0439849
27467251	894	903	potential	T080	C3245505
27467251	904	911	targets	T169	C1521840
27467251	913	921	pathways	T045	C1517508
27467251	923	931	networks	T044	C1720950
27467251	948	957	hub genes	T028	C0017337
27467251	963	971	revealed	T080	C0443289
27467251	996	1014	overlapped section	T086	C0314659
27467251	1016	1023	MiR-132	T114,T123	C2745279
27467251	1028	1037	effective	T080	C1704419
27467251	1046	1054	impeding	T169	C0205245
27467251	1055	1066	cell growth	T043	C0007595
27467251	1071	1079	boosting	T169	C1511253
27467251	1080	1089	apoptosis	T043	C0162638
27467251	1093	1096	HCC	T191	C2239176
27467251	1097	1107	cell lines	T025	C0085983
27467251	1120	1130	fifty-nine	T081	C3830128
27467251	1131	1136	genes	T028	C0017337
27467251	1160	1182	analytical integration	T169	C0205245
27467251	1195	1205	considered	T078	C0750591
27467251	1217	1220	HCC	T191	C2239176
27467251	1227	1234	miR-132	T114,T123	C2745279
27467251	1237	1244	related	T080	C0439849
27467251	1270	1278	pathways	T044	C0037080
27467251	1300	1316	network analysis	T170	C0868995
27467251	1324	1332	overlaps	T086	C0314659
27467251	1339	1356	adherens junction	T026	C0887872
27467251	1358	1380	VEGF signaling pathway	T044	C3271788
27467251	1382	1412	neurotrophin signaling pathway	T044	C2984256
27467251	1418	1440	MAPK signaling pathway	T043	C1518102
27467251	1446	1468	tumor-suppressive role	T043	C1325410
27467251	1472	1479	miR-132	T114,T123	C2745279
27467251	1483	1486	HCC	T191	C2239176
27467251	1504	1516	confirmed by	T080	C0521093
27467251	1517	1525	in vitro	T080	C1533691
27467251	1526	1537	experiments	T062	C0681814
27467251	1539	1554	Gene signatures	T169	C1708225
27467251	1562	1567	study	T062	C2603343
27467251	1583	1592	potential	T080	C3245505
27467251	1593	1613	molecular mechanisms	T169	C0441712
27467251	1617	1620	HCC	T191	C2239176
27467251	1622	1629	miR-132	T114,T123	C2745279
27467251	1652	1664	associations	T080	C0439849
27467251	1681	1690	effective	T080	C1704419
27467251	1695	1704	diagnosis	T062	C1704656
27467251	1706	1720	individualized	T080	C1881197
27467251	1721	1731	treatments	T061	C0087111
27467251	1736	1745	prognosis	T058	C0033325
27467251	1749	1752	HCC	T191	C2239176
27467251	1753	1761	patients	T101	C0030705
27467251	1772	1780	combined	T080	C0205195
27467251	1781	1791	detections	T061	C1511790
27467251	1795	1802	miR-132	T114,T123	C2745279
27467251	1814	1828	bio-indicators	T201	C0005516
27467251	1832	1849	clinical practice	T062	C0008972
27467251	1862	1870	in vitro	T080	C1533691
27467251	1871	1882	experiments	T062	C0681814
27467251	1887	1893	needed	T080	C0027552